1. Home
  2. Bills
  3. H.R. 7071

H.R. 7071 · 116th Congress · 2019–2020

Accelerating Access to Critical Therapies for ALS Act

H.R. 7071 in the 116th Congress (2019–2020) was introduced on Jun 1, 2020, sponsored by Jeff Fortenberry with 198 co-sponsors.

During the 116th Congress (2019–2020), Donald Trump was president, and Democrats held the House majority and Republicans the Senate majority.

Status
Introduced
Introduced
Jun 1, 2020
Co-sponsors
198
Policy area
Health

What it does

Accelerating Access to Critical Therapies for ALS Act This bill establishes a grant program, as well as a new center within the Food and Drug Administration (FDA), to facilitate access to investigational therapies for neurodegenerative diseases such as amyotrophic lateral sclerosis (i.e., ALS, also known as Lou Gehrig's disease, a progressive and fatal disease).

Summary by the nonpartisan Congressional Research Service.

Sponsor

Jeff Fortenberry (R-NE). Co-sponsors: 116 Democrats, 82 Republicans.

Where it stands

  • IntroducedJun 1, 2020
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Referred to the House Committee on Energy and Commerce. (Jun 1, 2020)

More bills from Jeff Fortenberry in the 116th Congress

Other Health bills in the 116th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 7071 (116th Congress): Accelerating Access to Critical…,” https://www.capitolreceipts.com/bill/116-hr-7071/accelerating-access-to-critical-therapies-for-als-act (accessed 2026-10-16).

Open the interactive version ›